TY  - JOUR
T1  - Role of Glucagon-like peptide-1 “Liraglutide” in Management of Type 1 Diabetes
A1  - Abdulrahman Jameel A Sehly
A1  - Rayyan Fahad H Altemani
A1  - Yousef Hussain J Alharthi
A1  - Aminah Ghanem S Alhwiti
A1  - Abdulaziz Abdulrahman A Bedaiwi
A1  - Waad Maher Alqulayti
A1  - Rakan Ahmed I Alshuwaier
A1  - Abdulrahman Saleh A Alaql
A1  - Ibrahim Mahmoud H Ajwah
JF  - International Journal of Pharmaceutical And Phytopharmacological Research
JO  - Int J Pharm Phytopharmacol Res
SN  - 2250-1029
Y1  - 2021
VL  - 11
IS  - 1
DO  - 10.51847/SkBDqRo7ng
SP  - 89
EP  - 93
N2  - Glucagon-like peptide-1 (GLP-1) overpowers glucagon secretion, endorses satiety, postpones gastric draining, and arouses peripheral glucose consumption. This systematic review was carried out including PubMed, Google Scholar, and EBSCO that examined randomized controlled trials, observational, and experimental studies that had studied the role of GLP-1 (liraglutide) in controlling juvenile diabetes. The study included 7 studies and concluded that the introduction of liraglutide to insulin treatment juvenile diabetic patients results in a considerable and fast decrease in glycemic excursions and a consequent reduction in insulin dose. Body weight decreases substantially as reported in many studies.
UR  - https://eijppr.com/article/role-of-glucagon-like-peptide-1-liraglutide-in-management-of-type-1-diabetes
ER  -